Symbol="HALO"
AssetType="Common Stock"
Name="Halozyme Therapeutics Inc"
Description="Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company is headquartered in San Diego, California."
CIK="1159036"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="11388 SORRENTO VALLEY ROAD, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="5032810000"
EBITDA="332883000"
PERatio="30.09"
PEGRatio="-2.5"
BookValue="0.5"
DividendPerShare="0"
DividendYield="0"
EPS="1.27"
RevenuePerShareTTM="5.18"
ProfitMargin="0.258"
OperatingMarginTTM="0.38"
ReturnOnAssetsTTM="0.117"
ReturnOnEquityTTM="1.114"
RevenueTTM="704980000"
GrossProfitTTM="454205000"
DilutedEPSTTM="1.27"
QuarterlyEarningsGrowthYOY="-0.326"
QuarterlyRevenueGrowthYOY="0.383"
AnalystTargetPrice="48.67"
TrailingPE="30.09"
ForwardPE="23.47"
PriceToSalesRatioTTM="13.28"
PriceToBookRatio="81.58"
EVToRevenue="15.76"
EVToEBITDA="31.48"
Beta="1.22"
num_52WeekHigh="59.46"
num_52WeekLow="29.85"
num_50DayMovingAverage="34.26"
num_200DayMovingAverage="43.71"
SharesOutstanding="131680000"
DividendDate="None"
ExDividendDate="None"
symbol="HALO"
open="38.74"
high="41.56"
low="38.36"
price="40.27"
volume="2628086.00"
latest_trading_day="2023-07-17"
previous_close="38.22"
change="2.05"
change_percent="5.3637%"
aroon_positive_momentum_days="6"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="6"
Volume_recent_avg="1433855"
Change_recent_avg="-0.1"
Delta_recent_avg="1.34"
Variance_recent_avg="0.67"
Change_ratio_recent_avg="-0.28"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="6"
Aroon_momentum_negative="94"
image_negative_thumbnail_id_1="1139"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0172.jpeg"
image_negative_thumbnail_id_2="509"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0096.jpeg"
image_neutral_thumbnail_id_1="591"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_neutral_thumbnail_id_2="521"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_positive_thumbnail_id_1="957"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0119.jpeg"
image_positive_thumbnail_id_2="987"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0149.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1200"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
